Court ruling in favor of Safe in its action against Neo Medical
February 05 2024 - 12:00PM
UK Regulatory
Court ruling in favor of Safe in its action against Neo Medical
Court ruling in favor of Safe in its action against Neo
Medical
Eragny-sur-Oise – France – February 5, 2024, 6pm
CET. Safe SA (the “Company”) announces that on January
26, 2024, the Paris Judicial Court found in favor of Safe in its
action against Neo Medical SA (Switzerland) and Neo Medical SASU
(France) (Neo Medical).
As a reminder, Safe took action against Neo Medical before the
Paris Judicial Court for infringement of its French patent FR 2 990
840 (the “patent”), unfair unfair competition and parasitic
business practices in 2017. In a judgment dated May 28, 2021, the
Paris Judicial Court found Neo Medical guilty of patent
infringement against Safe.
The decision of the Court of Appeal upheld the judgment of the
Paris Judicial Court insofar as it:
- - found that French patent Safe FR 2 990 840 was
valid,
- - found that Neo Medical had committed acts of
infringement to the detriment of Safe,
- - referred both parties back to amicable negotiation of
the damages suffered by Safe, failing which to refer the matter
before the Judicial Court to determine the damages.
- Finally, Neo Medical is ordered to pay Safe the sum of 50,000
euros under Article 700 of the French Code of Civil Procedure.
- About Safe Group Safe Group is a French medical
technology group that brings together Safe Orthopaedics, a pioneer
in ready-to-use technologies for spine pathologies, and Safe
Medical (formerly LCI Medical), a medical device subcontractor for
orthopedic surgeries. The group employs approximately 80 people.
Safe Orthopaedics develops and manufactures kits combining sterile
implants and ready-to-use instruments, available at any time to the
surgeon. These technologies are part of a minimally invasive
approach aimed at reducing the risks of contamination and
infection, in the interest of the patient and with a positive
impact on hospitalization times and costs. Protected by 15 patent
families, SteriSpineTM kits are CE marked and FDA approved. Safe
Orthopaedics has subsidiaries in the United Kingdom, Germany, the
United States. For more information:
http://www.safeorthopaedics.com/ Safe Medical produces implantable
medical devices and ready-to-use instruments. It has an innovation
center and two production sites in France and in Tunisia, offering
numerous industrial services: industrialization, machining,
finishing and sterile packaging.
For more information: http://www.safemedical.fr/
Contacts
SAFE GROUP
investors@safeorthopaedics.com
AELYON ADVISORS
safe@aelyonadvisors.fr
Safe Orthopaedics (LSE:0RAA)
Historical Stock Chart
From Aug 2024 to Sep 2024
Safe Orthopaedics (LSE:0RAA)
Historical Stock Chart
From Sep 2023 to Sep 2024